Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Pediatrics International : Official Journal of the Japan Pediatric Society|May 26, 2017
Inter-prefecture disparity in under-5 mortality: 115 year trend in JapanChie Nagata, Akinori Moriichi, Naho Morisaki, et al.
International Journal of Clinical Oncology|January 30, 2014
A retrospective study of urokinase-type plasminogen activator receptor (uPAR) as a prognostic factor in cancer of the uterine cervixToru Sasaki, Hirotaka Nishi, Chie Nagata, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|August 22, 2018
Risk factors of long hospital stay for immunoglobulin A vasculitis: Single-center studyErika Uehara, Chie Nagata, Hiroshi Masuda, et al.
The Journal of Obstetrics and Gynaecology Research|June 27, 2015
Randomized controlled trial of enoxaparin versus intermittent pneumatic compression for venous thromboembolism prevention in Japanese surgical patients with gynecologic malignancyChie Nagata, Hiroshi Tanabe, Satoshi Takakura, et al.
JMA Journal|November 5, 2020
Needs Assessment for Supports to Promote Pediatric Clinical Research Using an Online Survey of the Japanese Children's Hospitals AssociationOsamu Nomura, Toru Kobayashi, Chie Nagata, et al.
Journal of Epidemiology|June 6, 2017
Pre-pregnancy BMI-specific optimal gestational weight gain for women in JapanNaho Morisaki, Chie Nagata, Seung Chik Jwa, et al.
Obstetrics and Gynecology International|April 12, 2017
Successful Treatment of Caesarean Scar Pregnancies by Local Treatment OnlyShinji Tanigaki, Chie Nagata, Kazunori Ueno, et al.
The Cochrane Database of Systematic Reviews|April 21, 2017
Assessment and support during early labour for improving birth outcomesShinobu Kobayashi, Nobutsugu Hanada, Masayo Matsuzaki, et al.
The Journal of Obstetrics and Gynaecology Research|March 15, 2012
Risk factors of treatment discontinuation due to uterine bleeding in adenomyosis patients treated with dienogestChie Nagata, Satoshi Yanagida, Aikou Okamoto, et al.
Molecular Carcinogenesis|April 10, 2015
Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovaryNozomu Yanaihara, Yukihiro Hirata, Noriko Yamaguchi, et al.
Pageof 6